Respir Case Rep. 2018; 7(2): 59-62 | DOI: 10.5505/respircase.2018.78557

Ýloprost ve Bosentan Kombinasyon Tedavisi Uygulanan Bir Sjögren Sendromu Ýliþkili Pulmoner Hipertansiyon Olgusu

Ayþe Baha¹, Berkay Ekici², Nalan Ogan¹, Evrim Eylem Akpýnar^1
1Ufuk Üniversitesi Týp Fakültesi Göðüs Hastalýklarý Anabilim Dalý, Ankara
²Ufuk Üniversitesi Týp Fakültesi Kardiyoloji Anabilim Dalý, Ankara

Sjögren Sendromu (SS) ekzokrin glandlarýn lenfositik infiltrasyonu ile karakterize, romatoid artritten sonra ikinci en sýk görülen multisitem otoimmün hastalýktýr. Pulmoner tutulum %9-20 sýklýkta bildirilmiþtir ve genellikle hava yolu hastalýðý ya da interstisyel akciðer hastalýðý þeklinde görülür. Pulmoner Arteriyel Hipertansiyon (PAH) geliþimi SS’da çok nadir bir durumdur. SS iliþkili PAH’da hastalar genellikle fonksiyonel sýnýf WHO-III/IV’dür ve spesifik bir tedavi rejimi yoktur. PAH’ýn nonspesifik tedavisine ek olarak altta yatan hastalýðýn tedavisi önemlidir. Bu yazýdaki amacýmýz iloprost ve bosentan kombinasyon tedavisi altýnda izlediðimiz bir SS iliþkili PAH (SÝP) olgusunu takdim etmektir.

Anahtar Kelimeler: Sjögren Sendromu, Pulmoner Hipertansiyon, Kombinasyon Tedavisi, Ýloprost, Bosentan

---

A Case of Sjögren’s Syndrome-Related Pulmonary Arterial Hypertension Treated with Iloprost and Bosentan Combination Therapy

Ayþe Baha¹, Berkay Ekici², Nalan Ogan¹, Evrim Eylem Akpýnar^1
1Ufuk University Faculty of Medicine, Department of Pulmonary Medicine, Ankara, Turkey
²Ufuk University Faculty of Medicine, Department of Cardiology, Ankara, Turkey

Sjögren’s syndrome (SS), which is characterized by lymphocytic infiltration of the exocrine glands, is the second most common multisystem autoimmune disease after rheumatoid arthritis. Pulmonary involvement ranges from 9% to 20% and it usually occurs as an airway disease or interstitial lung disease. Pulmonary arterial hypertension (PAH) is a very rare condition in SS. In SS-associated PAH, the functional class of patients is usually World Health Organization (WHO) Class III/IV and there is no specific treatment regimen. In addition to nonspecific medical treatment for PAH, treatment of the underlying disease and supportive therapy are important. The aim of this manuscript was to present a case of SS-related PAH (SRP) followed under bosentan and iloprost combination therapy.

Keywords: Sjögren Syndrome, Pulmonary Hypertension, Combination Therapy, Iloprost, Bosentan

---

ATIF KOPYALA